$2.03
-0.04-1.93%
At close: -
$1.95
-0.08-3.84%
After Hours: 7:37 PM EDT
Track the latest NRX Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for NRX Pharmaceuticals stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Dec 18, 2024 | Jonathan C Javitt | CHAIRMAN AND CHIEF SCIENTIST | 40.00K | $1.17 | $46.80K | BUY | 53.59% | 114.63K | Dec 17 | View |
Sep 11, 2023 | Aaron Gorovitz | — | 35.00K | $0.32 | $11.20K | BUY | 50.00% | 105.00K | Aug 30 | View |
Sep 11, 2023 | Chaim Hurvitz | — | 70.00K | $0.29 | $20.13K | BUY | 9.88% | 778.44K | Aug 30 | View |
Aug 24, 2023 | Jonathan C Javitt | CHIEF SCIENTIST | 100.00K | $0.33 | $33.00K | BUY | 15.47% | 746.33K | Aug 23 | View |
Aug 23, 2023 | Jonathan C Javitt | CHIEF SCIENTIST | 200.00K | $0.32 | $64.40K | BUY | 44.81% | 646.33K | Aug 22 | View |
Dec 19, 2022 | Stephen Willard | CHIEF EXECUTIVE OFFICER | 50.00K | $1.17 | $58.50K | BUY | ∞ | 50.00K | Dec 16 | View |
Dec 19, 2022 | Seth Van Voorhees | CHIEF FINANCIAL OFFICER | 30.00K | $1.10 | $33.00K | BUY | 183.63% | 46.34K | Dec 16 | View |
Dec 09, 2022 | Jonathan C Javitt | — | -400.00K | $1.00 | -$400.00K | SELL | -2.97% | 13.05M | Dec 07 | View |
Dec 01, 2022 | Daniel Javitt | 10% OWNER | -22.17K | $1.50 | -$33.35K | SELL | -0.23% | 9.63M | Nov 29 - Nov 30 | View |
Nov 29, 2022 | Patrick J Flynn | — | 11.75K | $1.25 | $14.66K | BUY | ∞ | 1.75K | Nov 28 | View |
Nov 28, 2022 | Seth Van Voorhees | CHIEF FINANCIAL OFFICER | 16.34K | $1.11 | $18.22K | BUY | 40842.50% | 16.38K | Nov 25 | View |
Nov 21, 2022 | Chaim Hurvitz | DIRECTOR | 500.00K | $1.03 | $514.91K | BUY | 239.87% | 708.44K | Nov 16 - Nov 18 | View |
Nov 18, 2022 | Daniel Javitt | 10% OWNER | -166.74K | $1.03 | -$171.14K | SELL | -1.70% | 9.66M | Nov 16 - Nov 17 | View |
Nov 15, 2022 | Daniel Javitt | 10% OWNER | -49.20K | $1.01 | -$49.51K | SELL | -0.50% | 9.82M | Nov 11 | View |
Aug 02, 2022 | Daniel Javitt | 10% OWNER | -784.06K | $1.01 | -$791.43K | SELL | -7.36% | 9.87M | Jul 29 | View |
Jun 07, 2022 | Daniel Javitt | 10% OWNER | -445.71K | $0.68 | -$303.91K | SELL | -3.40% | 12.66M | Jun 03 - Jun 07 | View |
Jun 02, 2022 | Jonathan C Javitt | CHIEF SCIENTIST | 100.00K | $58.00 | $5.80M | BUY | 6.81% | 1.57M | Jun 01 | View |
Nov 02, 2021 | Alessandra Daigneault | GENERAL COUNSEL & SECRETARY | 25.26K | $8.09 | -$260.94K | SELL-OPTIONS | 399.75% | 31.58K | Aug 19 - Sep 02 | View |
Nov 02, 2021 | Robert Besthof | CHIEF COMM. & PATIENT OFFICER | 23.71K | $5.98 | -$457.66K | SELL-OPTIONS | ∞ | 23.71K | Aug 16 - Sep 15 | View |
Browse insider trades on all stocks.